gefitinib Roche EGFR Mutation Test Approved by FDA as Companion Diagnostic for NSCLC Roche's real-time PCR test detects defined mutations of the epidermal growth factor receptor gene in DNA from non-small cell lung cancer patients. Foundation Medicine Liquid Biopsy Gets FDA Approval for Multiple Companion Diagnostic Indications The agency approved the test for use across solid tumors and with multiple companion diagnostic indications including one for prostate cancer and three for lung cancer. China's NMPA Extends Approval for Roche Cobas EGFR Mutation Test v2 to Plasma Samples Labs in China can now use the Cobas EGFR Mutation Test v2 with either tissue or plasma samples as a CDx for three Roche oncology drugs in NSCLC patients. FDA Approves Roche Cobas EGFR Mutation Test as CDx for Iressa The approval includes the use of either tumor tissue or plasma and follows previous approvals with Genentech's Tarceva (erlotinib) and AstraZeneca's Tagrisso (osimertinib). Lung Cancer Study Investigates Role of Protein Modifications in Cell Signaling, Drug Response Premium The study combined large-scale protein post-translational modification datasets with protein-protein interaction data to profile cell signaling in lung cancer. Jun 27, 2016 Precision Lung Cancer Drugs on Pricing Evaluation Group's Agenda Premium Jul 14, 2015 Iressa Approval Grows Options for Lung Cancer Patients as AstraZeneca Re-establishes Presence Premium Jul 13, 2015 FDA Approves Qiagen's Therascreen EGFR Test as CDx for AstraZeneca NSCLC Drug Breaking News People in the News at Pacific Biosciences, Metabolon, NeoGenomics, More New Products Posted to GenomeWeb: Tethis, Invitae, PerkinElmer, More In Brief This Week: Thermo Fisher Scientific, Bruker, Quantum-Si, BioMérieux, More Luminex Obtains CE Marking for MDx Panel to Detect Flu A/B, RSV, COVID-19 Palmetto Finalizes Positive LCD for Prostate Cancer Risk Tests Gene Expression, Histology Reveal Clues for Targeted Rheumatoid Arthritis Treatment The Scan Call for a Different Tack Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News. Wastewater Warning The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge. Can't Get in the Program Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports. Science Paper on Spatial-Controlled Genome Editing In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.